Family Office · Volketswil, Switzerland
Valterna AG is a Swiss-based company specializing in the development and commercialization of advanced cell and gene therapies. Founded in 2022, Valterna focuses on innovative treatments for age-related diseases and longevity, leveraging proprietary technology platforms to target cellular rejuvenation. The company has gained attention for its scientific leadership and collaborations with leading research institutions. Valterna AG is headquartered in Zug, Switzerland, and is recognized for its commitment to pioneering therapies in the biotechnology sector.
Business models
services
Customer segments
Mid-market, Enterprise, Consumer
Geography
Europe
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Valterna AG deploys privately-held capital. Cycles are short, decisions concentrated, and structures flexible (equity, convertible, revenue-share). Less brand premium, more underwriting on substance. VCboom tracks Valterna AG alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. AI scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Valterna AG is one of them — and we'll tell you exactly where they sit in your top 100.